-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bp+SRrETAHXkpxI/p54rm9Tz4RALpmi0T8SUfB95EFkZ667+ioI+Npo7dlmr30VA q9ZFM7MjbbmUPDzyQ6ymIQ== 0001145443-10-002790.txt : 20101203 0001145443-10-002790.hdr.sgml : 20101203 20101203145239 ACCESSION NUMBER: 0001145443-10-002790 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101129 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20101203 DATE AS OF CHANGE: 20101203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VYCOR MEDICAL INC CENTRAL INDEX KEY: 0001424768 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 203369218 STATE OF INCORPORATION: DE FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34932 FILM NUMBER: 101231125 BUSINESS ADDRESS: STREET 1: 80 ORVILLE DRIVE STREET 2: SUITE 100 CITY: BOHEMIA STATE: NY ZIP: 11716 BUSINESS PHONE: 631 244 1435 MAIL ADDRESS: STREET 1: 80 ORVILLE DRIVE STREET 2: SUITE 100 CITY: BOHEMIA STATE: NY ZIP: 11716 8-K 1 d27583_8k.htm 8-K HTML


     
      
  UNITED STATES  
  SECURITIES AND EXCHANGE COMMISSION  
  Washington, D.C. 20549  
     
  Form 8-K  
     
  CURRENT REPORT  
     
  Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934		  
     
  Date of Report (Date of earliest event reported):
November 29, 2010 		 
     
      
     
  Vycor Medical, Inc.  
  (Exact name of registrant)  
     
     
                             
  Delaware           333-149782           20-3369218  
  (State of Incorporation)           (Commission File Number)           (I.R.S. Employer Identification Number)  
     
     
     
  80 Orville Drive
Suite 100
Bohemia, NY 11716 		 
  (Address of principal executive offices and zip code)  
     
  631-244-1435  
  (Registrant's telephone number, including area code)  
     
      

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     
      

Item 2.01. Completion of Acquisition or Disposition of Assets.

On November 29, 2010, Vycor Medical, Inc. ("Vycor" or the "Company") completed its acquisition (the "Acquisition") of substantially all of the assets of NovaVision, Inc., a company that had been in the business of researching, developing and providing medical technologies to restore the vision of patients with neurological visual loss ("NovaVision"). The Acquisition was made pursuant to an Asset Purchase Agreement (the "Purchase Agreement"), dated November 5, 2010, between Vycor and Michael R. Bakst, the Chapter 7 trustee of NovaVision. The purchase price for the Acquisition was $900,000 in cash.

The foregoing description of the terms of the Acquisition is qualified by reference to the Purchase Agreement, which is incorporated herein by reference to Vycor's Current Report on Form 8-K filed on November 12, 2010.

Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired

The financial statements required by this item are not included in this Current Report on form 8-K. The financial statements will be provided in an amended report, which will be filed not later than 71 calendar days after the date that this initial report on Form 8-K must be filed.

(b) Pro Forma Financial Information

The pro forma financial information required by this item is not included in this Current Report on form 8-K. The pro forma financial information will be provided in an amended report, which will be filed not later than 71 calendar days after the date that this initial report on Form 8-K must be filed.

(d) Exhibits

None

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                 
           
        VYCOR MEDICAL, INC.  
                 
        By:     /s/ David Cantor  
        Name:     David Cantor  
        Title:     President  
                 

Dated: December 3, 2010

 -----END PRIVACY-ENHANCED MESSAGE-----